OpenVSafe by OpenVAERS
Search V-safe

2GR-14075-74410

2 vaccinations 1 coded response 18 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
981 / WA
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-04
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-01-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-05
    Survey response — 3 months, dose 2
    MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Preeclampsia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-05
    Report sent to call center — 3 months, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-05-17
    Call successful
    Participant prefers to complete VAERS report online
  23. 2021-07-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-04Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-05 Successful
2021-05-17
 Participant prefers to complete VAERS report online

Free text

Release 6 — 3 months, dose 2

2021-04-05

Symptoms: Preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPre-eclampsia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…